Description
The purpose of this Program Announcement (PAR) is to enable clinical validation of strong candidate biomarkers for neurological diseases and conditions. Specifically, the goal of this PAR is to enable the rigorous validation of biomarker measurements within the clinical population of interest to establish the positive and negative predictive values of the candidate biomarker consistent with FDA guidelines. This PAR assumes that 1) a candidate biomarker has already been identified, 2) detection method technology has already been developed and analytically validated, and 3) the research and/or clinical need and potential context of use has been identified.
• The opportunity is open to various applicant types, including small businesses, public housing authorities, Native American tribal organizations, and more.
• The funding instrument for this opportunity is a Cooperative Agreement.
• The opportunity is listed under the health category.
• The expected application count is 100, and the expected application size is 0.